Janux Therapeutics, Inc. (JANX)
Largest Insider Buys in Sector
JANX Stock Price History Chart
JANX Stock Performance
About Janux Therapeutics, Inc.
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. Janux Therapeutics, Inc. is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. In addition, its EGFR-TRACTr is designed to target EGFR in many cancer types with multiple approved monoclonal antibodies. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Insider Activity of Janux Therapeutics, Inc.
Over the last 12 months, insiders at Janux Therapeutics, Inc. have bought $21.13M and sold $209.29M worth of Janux Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Janux Therapeutics, Inc. have bought $64.12M and sold $115.24M worth of stock each year.
Highest buying activity among insiders over the last 12 months: RA CAPITAL MANAGEMENT, L.P. () — $154.19M. Reardon Tighe (Acting Chief Financial Officer) — $4.99M. Avalon Ventures XI, L.P. (10 percent owner) — $4.99M.
The last purchase of 849,854 shares for transaction amount of $4.99M was made by Reardon Tighe (Acting Chief Financial Officer) on 2023‑11‑13.
List of Insider Buy and Sell Transactions, Janux Therapeutics, Inc.
| 2024-06-03 | Sale | Reardon Tighe | Acting Chief Financial Officer | 822,721 1.5801% | $54.75 | $45.04M | -22.92% | |
| 2024-06-03 | Sale | Lichter Jay | 1.5M 2.8808% | $54.75 | $82.13M | -22.92% | ||
| 2024-06-03 | Sale | Avalon Ventures XI, L.P. | 10 percent owner | 1.5M 2.8808% | $54.75 | $82.13M | -22.92% | |
| 2023-11-13 | Reardon Tighe | Acting Chief Financial Officer | 849,854 1.538% | $5.87 | $4.99M | +430.86% | ||
| 2023-11-13 | Lichter Jay | 849,854 1.538% | $5.87 | $4.99M | +430.86% | |||
| 2023-11-13 | Avalon Ventures XI, L.P. | 10 percent owner | 849,854 1.538% | $5.87 | $4.99M | +430.86% | ||
| 2023-07-19 | RA CAPITAL MANAGEMENT, L.P. | 495,008 1.1638% | $12.46 | $6.17M | -13.34% | |||
| 2021-12-29 | Sale | Thompson Peter A. | director | 40,400 0.1004% | $20.30 | $820,120 | -30.21% | |
| 2021-12-29 | Sale | ORBIMED ADVISORS LLC | director | 40,400 0.1004% | $20.30 | $820,120 | -30.21% | |
| 2021-12-21 | Sale | Thompson Peter A. | director | 119,400 0.2901% | $19.00 | $2.27M | -26.45% | |
| 2021-12-21 | Sale | ORBIMED ADVISORS LLC | director | 119,400 0.2901% | $19.00 | $2.27M | -26.45% | |
| 2021-12-16 | Sale | Thompson Peter A. | director | 393,300 0.9489% | $19.07 | $7.5M | -26.90% | |
| 2021-12-16 | Sale | ORBIMED ADVISORS LLC | director | 393,300 0.9489% | $19.07 | $7.5M | -26.90% | |
| 2021-06-15 | RA CAPITAL MANAGEMENT, L.P. | 2.94M 26.8213% | $17.00 | $50M | +1.61% | |||
| 2021-06-15 | Reardon Tighe | Acting Chief Financial Officer | 629,411 5.7397% | $17.00 | $10.7M | +1.61% | ||
| 2021-06-15 | Lichter Jay | 629,411 5.7397% | $17.00 | $10.7M | +1.61% | |||
| 2021-06-15 | Avalon Ventures XI, L.P. | 10 percent owner | 629,411 5.7397% | $17.00 | $10.7M | +1.61% | ||
| 2021-06-15 | Bregua Corp | 10 percent owner | 58,823 0.5364% | $17.00 | $999,991 | +1.61% | ||
| 2021-06-15 | Thompson Peter A. | director | 705,853 6.4368% | $17.00 | $12M | +1.61% | ||
| 2021-06-15 | ORBIMED ADVISORS LLC | director | 705,853 6.4368% | $17.00 | $12M | +1.61% |
Insider Historical Profitability
| RA CAPITAL MANAGEMENT, L.P. | 8117246 17.5818% | $39.80 | 2 | 0 | +1.61% | |
| Lichter Jay | 633673 1.8408% | $39.80 | 2 | 1 | +1.61% | |
| Reardon Tighe | Acting Chief Financial Officer | 633673 1.8408% | $39.80 | 2 | 1 | +1.61% |
| Avalon Ventures XI, L.P. | 10 percent owner | 633673 1.8408% | $39.80 | 2 | 1 | +1.61% |
| Bregua Corp | 10 percent owner | 3749250 8.1208% | $39.80 | 1 | 0 | +1.61% |
| Thompson Peter A. | director | 231098 0.5006% | $39.80 | 1 | 3 | +1.61% |
| ORBIMED ADVISORS LLC | director | 231098 0.5006% | $39.80 | 1 | 3 | +1.61% |
Institutional Investor Ownership
| RA Capital Management, L.P. | $345.09M | 17.68 | 9.17M | 0% | +$0 | 0.35 | |
| Fidelity Investments | $291.75M | 14.95 | 7.75M | +65.89% | +$115.88M | 0.02 | |
| OrbiMed | $160.97M | 8.25 | 4.28M | +28.86% | +$36.05M | 3.29 | |
| Bvf Inc Il | $109.93M | 5.63 | 2.92M | -36.25% | -$62.5M | 0.81 | |
| Adage Capital Partners Gp L L C | $104.5M | 5.35 | 2.78M | +104.78% | +$53.47M | 0.19 | |
| Citadel Advisors LLC | $88.49M | 4.53 | 2.35M | -24.68% | -$28.99M | 0.06 | |
| Janus Henderson | $73.96M | 3.79 | 1.97M | +1.76% | +$1.28M | 0.04 | |
| BlackRock | $63.78M | 3.27 | 1.69M | -3.87% | -$2.56M | <0.01 | |
| The Vanguard Group | $51.13M | 2.62 | 1.36M | +38.64% | +$14.25M | <0.01 | |
| RTW Investments, LP | $37.65M | 1.93 | 1M | New | +$37.65M | 0.56 | |
| Cormorant Asset Management Lp | $28.24M | 1.45 | 750,000 | New | +$28.24M | 1.34 | |
| Lord Abbett | $20.42M | 1.05 | 542,373 | New | +$20.42M | 0.07 | |
| Geode Capital Management | $17.61M | 0.9 | 467,547 | +14.54% | +$2.24M | <0.01 | |
| State Street | $15.04M | 0.77 | 399,467 | +14.93% | +$1.95M | <0.01 | |
| Avidity Partners Management Lp | $14.47M | 0.74 | 384,245 | New | +$14.47M | 0.53 | |
| Goldman Sachs | $13.07M | 0.67 | 347,171 | +769.06% | +$11.57M | <0.01 | |
| Samlyn Capital, LLC | $11.16M | 0.57 | 296,391 | New | +$11.16M | 0.2 | |
| Two Sigma | $8.46M | 0.43 | 224,720 | +409.48% | +$6.8M | 0.02 | |
| Northern Trust | $7.6M | 0.39 | 201,983 | -0.99% | -$76,015.35 | <0.01 | |
| Alyeska Investment Group L P | $7.27M | 0.37 | 193,046 | -2.25% | -$167,316.60 | 0.05 | |
| Driehaus Capital Management LLC | $7.19M | 0.37 | 191,055 | New | +$7.19M | 0.07 | |
| Samsara Biocapital Llc | $6.78M | 0.35 | 180,207 | -50% | -$6.78M | 1.06 | |
| Soleus Capital Management, L.P. | $5.94M | 0.3 | 157,800 | New | +$5.94M | 0.06 | |
| Schonfeld Group | $5.75M | 0.3 | 152,721 | New | +$5.75M | 0.04 | |
| Logos Global Management Lp | $5.65M | 0.29 | 150,000 | New | +$5.65M | 0.61 | |
| Morgan Stanley | $4.56M | 0.23 | 121,231 | +79.74% | +$2.02M | <0.0001 | |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | $3.93M | 0.2 | 104,500 | New | +$3.93M | 0.37 | |
| Renaissance Technologies | $3.5M | 0.18 | 92,899 | New | +$3.5M | 0.01 | |
| Two Sigma Advisers LP | $3.12M | 0.16 | 83,000 | +251.69% | +$2.24M | 0.01 | |
| Candriam S C A | $3.01M | 0.15 | 80,005 | New | +$3.01M | 0.02 | |
| Nuveen | $2.96M | 0.15 | 78,625 | -3.62% | -$111,029.84 | <0.01 | |
| Atika Capital Management Llc | $2.43M | 0.12 | 64,500 | New | +$2.43M | 0.28 | |
| Macquarie Group | $2.26M | 0.12 | 60,000 | New | +$2.26M | <0.01 | |
| Eam Investors | $2.11M | 0.11 | 55,973 | New | +$2.11M | 0.33 | |
| D. E. Shaw & Co. | $2.06M | 0.11 | 54,638 | New | +$2.06M | <0.01 | |
| Capstone Investment Advisors | $1.97M | 0.1 | 52,300 | New | +$1.97M | 0.07 | |
| Artal Group S A | $1.88M | 0.1 | 50,000 | New | +$1.88M | 0.01 | |
| DekaBank | $1.88M | 0.1 | 49,500 | 0% | +$0 | <0.01 | |
| Charles Schwab | $1.85M | 0.1 | 49,258 | +6.75% | +$117,355.07 | <0.0001 | |
| BNY Mellon | $1.83M | 0.09 | 48,687 | -7.7% | -$152,821.39 | <0.0001 | |
| Artia Global Partners Lp | $1.81M | 0.09 | 47,949 | New | +$1.81M | 0.45 | |
| Squarepoint Ops LLC | $1.62M | 0.08 | 43,151 | -29.45% | -$678,339.99 | 0.01 | |
| Citigroup | $1.57M | 0.08 | 41,572 | +986.28% | +$1.42M | <0.01 | |
| Zacks Investment Management | $1.54M | 0.08 | 40,919 | -30.41% | -$673,373.16 | 0.02 | |
| Voya Investment Management LLC | $1.53M | 0.08 | 40,653 | New | +$1.53M | <0.01 | |
| Ovata Capital Management Ltd | $1.51M | 0.08 | 40,000 | New | +$1.51M | 1.09 | |
| Laurion Capital Management LP | $1.51M | 0.08 | 40,000 | New | +$1.51M | 0.04 | |
| Swiss National Bank | $1.2M | 0.06 | 31,800 | 0% | +$0 | <0.01 | |
| Wellington Management Company | $1.19M | 0.06 | 31,595 | New | +$1.19M | <0.0001 | |
| Woodline Partners LP | $1.12M | 0.06 | 29,848 | New | +$1.12M | 0.01 |